Victory Capital Management Inc. grew its position in Xylem Inc. (NYSE:XYL - Free Report) by 42.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,326,024 shares of the industrial products company's stock after purchasing an additional 698,745 shares during the quarter. Victory Capital Management Inc. owned approximately 0.96% of Xylem worth $269,865,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Heck Capital Advisors LLC purchased a new position in Xylem during the fourth quarter valued at $36,000. SRS Capital Advisors Inc. grew its position in shares of Xylem by 69.5% during the fourth quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock valued at $37,000 after purchasing an additional 130 shares in the last quarter. Pathway Financial Advisers LLC increased its holdings in shares of Xylem by 122.4% in the fourth quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock worth $37,000 after purchasing an additional 175 shares during the last quarter. Assetmark Inc. lifted its position in shares of Xylem by 3,887.5% in the third quarter. Assetmark Inc. now owns 319 shares of the industrial products company's stock worth $43,000 after buying an additional 311 shares in the last quarter. Finally, Catalyst Capital Advisors LLC boosted its stake in Xylem by 226.0% during the third quarter. Catalyst Capital Advisors LLC now owns 339 shares of the industrial products company's stock valued at $46,000 after buying an additional 235 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
Xylem Trading Down 0.5 %
Shares of XYL traded down $0.71 during mid-day trading on Thursday, reaching $128.96. 1,494,560 shares of the company's stock traded hands, compared to its average volume of 1,198,949. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.76 and a quick ratio of 1.33. The stock's 50-day moving average is $123.29 and its two-hundred day moving average is $127.10. Xylem Inc. has a 12 month low of $113.26 and a 12 month high of $146.08. The stock has a market cap of $31.33 billion, a P/E ratio of 35.23, a P/E/G ratio of 2.33 and a beta of 1.07.
Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, topping analysts' consensus estimates of $1.12 by $0.06. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The company's quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company posted $0.99 earnings per share. Research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th will be issued a $0.40 dividend. This is an increase from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a dividend yield of 1.24%. The ex-dividend date of this dividend is Tuesday, February 18th. Xylem's payout ratio is presently 43.72%.
Analyst Ratings Changes
Several analysts have recently issued reports on the company. TD Cowen decreased their price objective on Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a report on Wednesday, November 6th. Citigroup downgraded shares of Xylem from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 5th. Stifel Nicolaus dropped their price objective on shares of Xylem from $166.00 to $150.00 and set a "buy" rating for the company in a research note on Friday, January 24th. Robert W. Baird upped their target price on shares of Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a research report on Wednesday, February 5th. Finally, Wolfe Research reaffirmed a "peer perform" rating on shares of Xylem in a report on Thursday, December 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $149.90.
Get Our Latest Stock Analysis on XYL
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.